Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 70, Issue 3, 2001, Pages 163-169

  Mariani, G ^a   Tagliabue, P ^a   Zucchinelli, P ^b   Brambilla, C ^a   Demicheli, R ^a   Villa, E ^b   Marchiano A ^a   Valagussa, P ^a   Bonadonna, G ^a   Gianni, L ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Gemcitabine vinorelbine chemotherapy; Metastatic breast cancer; Phase I II study

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; GEMCITABINE; NAVELBINE; TAXANE DERIVATIVE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN HEMORRHAGE; BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MAXIMUM TOLERATED DOSE; METASTASIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGRANULOCYTOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MAXIMUM TOLERATED DOSE; MENOPAUSE; MIDDLE AGED; VINBLASTINE;

EID: 0035666849     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013034311284     Document Type: Article

References (26)

1. Cancer of the breast. Management of metastatic disease
2. Biochemical effects of Navelbine on tubulin and associated proteins
3. Vinorelbine (Navelbine) in the treatment of breast cancer: The European experience
4. Synthesis of 2-deoxy-2′,2′- difluoro-D-ribose and 2-deoxy-2′,2prime;-difluoro-D-ribofuranosyl nucleosides
5. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro -2′-deoxycytidine)
6. Gemcitabine for palliative treatment in metastatic breast cancer
7. Phase II study of gemcitabine in patients with metastatic breast cancer
8. Gemcitabine in advanced breast cancer
9. Advanced breast cancer: A phase II trial with gemcitabine
10. Activity of gemcitabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containing regimens
11. Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: The Eastern Cooperative Oncology Group experience
12. Paclitaxel by three-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study
13. Vinorelbine: An active non cross-resistant drug in advanced breast cancer. Results from a phase II study
14. Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): A phase I trial
15. Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: A pilot study
16. Vinorelbine-gemcitabine in advanced non-small cell lung cancer (NSCLC): An AASLC phase II trial
17. Gemcitabine and vinorelbine in the second-line treatment of non-small cell lung carcinoma patients. A Minnie Pearl Cancer Research Network phase II trial
18. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progression after first-line taxane-based chemotherapy. A phase II study conducted by the Hellenic Cooperative Oncology Group
19. Gemcitabine and vinorelbine in pretrated advanced breast cancer: A pilot study
20. New drugs in the treatment of Hodgkin's disease
21. A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
22. Gemcitabine and vinorelbine combination in patients older than 70 years or unresponsive to a cisplatin chemotherapy in advanced bladder cancer
23. Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma. A phase II study
24. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small cell lung cancer
25. Five-days infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients
26. Five-days infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxel